Nuclear and fluorescent labeled PD-1-Liposome-DOX-64Cu/IRDye800CW allows improved breast tumor targeted imaging and therapy

	Nuclear and fluorescent labeled PD-1-Liposome-DOX-64Cu/IRDye800CW allows improved breast tumor targeted imaging and therapy
	Du Yang; Liang Xiaolong; Li Yuan; Sun Ting; Jin Zhengyu; Xue Huadan; Tian Jie
发表期刊	Molecular Pharmaceutics
	2017-11-06
卷号	14 期号:11 页码:3978-3986
摘要	see the attachment
关键词	Programmed Cell Death-1 (Pd-1), Near-infrared Fluorescence (Nirf) Imaging, Pet Imaging, Doxorubicin (Dox), Breast Cancer, Therapy
语种	英语
文献类型	期刊论文
条目标识符	http://ir.ia.ac.cn/handle/173211/23185
专题	中国科学院分子影像重点实验室
通讯作者	Xue Huadan; Tian Jie
推荐引用方式 GB/T 7714	Du Yang,Liang Xiaolong,Li Yuan,et al. Nuclear and fluorescent labeled PD-1-Liposome-DOX-64Cu/IRDye800CW allows improved breast tumor targeted imaging and therapy[J]. Molecular Pharmaceutics,2017,14(11):3978-3986.
APA	Du Yang.,Liang Xiaolong.,Li Yuan.,Sun Ting.,Jin Zhengyu.,...&Tian Jie.(2017).Nuclear and fluorescent labeled PD-1-Liposome-DOX-64Cu/IRDye800CW allows improved breast tumor targeted imaging and therapy.Molecular Pharmaceutics,14(11),3978-3986.
MLA	Du Yang,et al."Nuclear and fluorescent labeled PD-1-Liposome-DOX-64Cu/IRDye800CW allows improved breast tumor targeted imaging and therapy".Molecular Pharmaceutics 14.11(2017):3978-3986.